FRMD6 and glioblastoma: To determine whether FRMD6 exerts its anti-GBM effect through or partially through inhibiting c-Met RTK activity, we investigated whether expression a constitutively active c-Met kinase, the TPR-Met fusion protein [18], reverses or partially reverses the anti-GBM effect of FRMD6.